These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 6872056)
1. [Current problems of neurological treatment in the aged]. Klimková-Deutschová E Cesk Neurol Neurochir; 1983 May; 46(3):144-7. PubMed ID: 6872056 [No Abstract] [Full Text] [Related]
2. [Neurological tolerance of lithium-psychotropic drugs association (author's transl)]. Braccini T; Coat C; Lavagna J; Myquel M; Darcourt G Encephale; 1981; 7(1):29-43. PubMed ID: 7227283 [TBL] [Abstract][Full Text] [Related]
3. [Off-label use of drugs in psychiatry and neurology]. Wallesch CW Fortschr Neurol Psychiatr; 2004 May; 72(5):243-4. PubMed ID: 15136944 [No Abstract] [Full Text] [Related]
4. Cutaneous reactions to neurologic drugs. Ahrens EM Neurol Clin; 1987 Aug; 5(3):499-514. PubMed ID: 2957583 [TBL] [Abstract][Full Text] [Related]
5. [Interaction between neurological and psychological control mechanisms]. Robberstad M Tidsskr Nor Laegeforen; 1983 Feb; 103(4):295-7. PubMed ID: 6857611 [No Abstract] [Full Text] [Related]
6. [Neurological symptoms in newborn infants as a result of the use of psychopharmaceuticals during pregnancy]. Hadders-Algra M Ned Tijdschr Geneeskd; 1993 Nov; 137(45):2337. PubMed ID: 8255345 [No Abstract] [Full Text] [Related]
7. Editorial of special issue - Synthetic psychoactive substances and neurological diseases: Toxic and therapeutic effects. Simola N; De Luca MA Exp Neurol; 2022 Jan; 347():113921. PubMed ID: 34782305 [No Abstract] [Full Text] [Related]
8. [Psychopharmacology in the psychogeriatric domain: current data, problems, perspectives]. Lima CA; Eap CB; Baumann P Rev Med Suisse Romande; 2000 Feb; 120(2):131-6. PubMed ID: 10748699 [No Abstract] [Full Text] [Related]
9. [An increased incidence of megacolon in psychiatric and neurologic patients]. Fehlow P; Walther F; Miosge W Nervenarzt; 1995 Jan; 66(1):57-9. PubMed ID: 7885515 [TBL] [Abstract][Full Text] [Related]
10. [Psychopharmaceuticals in neurology]. Kohlmeyer K Med Welt; 1975 Jun; 26(25):1230-3. PubMed ID: 1226125 [No Abstract] [Full Text] [Related]
11. Proof of efficacy of nootropics for the indication "dementia" (phase III)--recommendations. Menges K Pharmacopsychiatry; 1992 May; 25(3):126-35. PubMed ID: 1635931 [No Abstract] [Full Text] [Related]
13. [Psychotropic drugs and the kidney (author's transl)]. Milutinović S Lijec Vjesn; 1980 Nov; 102(11):647-51. PubMed ID: 7278487 [No Abstract] [Full Text] [Related]
14. Neurologic side effects of psychiatric treatments. Dolan RJ Semin Neurol; 1990 Sep; 10(3):295-302. PubMed ID: 2259808 [No Abstract] [Full Text] [Related]
15. Testosterone replacement therapy for the treatment of neurological and neuropsychiatric disorders. Gold SM; Voskuhl RR Curr Opin Investig Drugs; 2006 Jul; 7(7):625-30. PubMed ID: 16869115 [TBL] [Abstract][Full Text] [Related]
16. [Prescription of drugs without registered indication]. Wetterling T Fortschr Neurol Psychiatr; 2004 May; 72(5):245-54. PubMed ID: 15136945 [TBL] [Abstract][Full Text] [Related]
17. [CYP genotyping in psychopharmacological treatment]. Rudberg I; Solberg DK; Refsum H Tidsskr Nor Laegeforen; 2005 Nov; 125(21):2953-5. PubMed ID: 16276380 [No Abstract] [Full Text] [Related]
18. [Indications for and prescription of psychotropic drugs in child and adolescent psychiatry]. Moor L Neuropsychiatr Enfance Adolesc; 1981 Oct; 29(10):537-42. PubMed ID: 7301061 [No Abstract] [Full Text] [Related]